Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
NASDAQ:SHPH
US Market
Holding SHPH?
Track your performance easily

Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Price & Analysis

17 Followers

SHPH Stock Chart & Stats


Financials

Annual

Ownership Overview

33.93%0.22%0.06%65.79%
33.93% Insiders
0.06% Other Institutional Investors
65.79% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

SHPH FAQ

What was Shuttle Pharmaceuticals Holdings, Inc.’s price range in the past 12 months?
Shuttle Pharmaceuticals Holdings, Inc. lowest stock price was $0.35 and its highest was $1.05 in the past 12 months.
    What is Shuttle Pharmaceuticals Holdings, Inc.’s market cap?
    Currently, no data Available
    When is Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date?
    Shuttle Pharmaceuticals Holdings, Inc.’s upcoming earnings report date is May 14, 2024 which is 110 days ago.
      How were Shuttle Pharmaceuticals Holdings, Inc.’s earnings last quarter?
      Shuttle Pharmaceuticals Holdings, Inc. released its earnings results on Nov 14, 2023. The company reported -$0.114 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.114.
        Is Shuttle Pharmaceuticals Holdings, Inc. overvalued?
        According to Wall Street analysts Shuttle Pharmaceuticals Holdings, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Shuttle Pharmaceuticals Holdings, Inc. pay dividends?
          Shuttle Pharmaceuticals Holdings, Inc. does not currently pay dividends.
          What is Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate?
          Shuttle Pharmaceuticals Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Shuttle Pharmaceuticals Holdings, Inc. have?
          Shuttle Pharmaceuticals Holdings, Inc. has 16,794,893 shares outstanding.
            What happened to Shuttle Pharmaceuticals Holdings, Inc.’s price movement after its last earnings report?
            Shuttle Pharmaceuticals Holdings, Inc. reported an EPS of -$0.114 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.5%.
              Which hedge fund is a major shareholder of Shuttle Pharmaceuticals Holdings, Inc.?
              Currently, no hedge funds are holding shares in SHPH
              ---

              Shuttle Pharmaceuticals Holdings, Inc. Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -59.61%
              12-Months-Change

              Fundamentals

              Return on Equity
              -152.02%
              Trailing 12-Months
              Asset Growth
              -54.45%
              Trailing 12-Months

              Company Description

              Shuttle Pharmaceuticals Holdings, Inc.

              Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Amicus
              Cytokinetics
              Aldeyra Therapeutics
              Kala Pharmaceuticals
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis